Hydrogel spacing,
visibly different.
The new SpaceOAR Vue™ Hydrogel is an absorbable hydrogel spacer designed to protect your patient’s rectum by minimising negative radiation side effects during prostate cancer treatment. It is safe, easily injectable and visible on CT scan, intended to improve contouring accuracy and to potentially optimise treatment planning. See how it works and watch recorded webinars from international experts.
Indications, Safety and Warnings
References
1. Mariados N, Sylvester J, Shah D, et al. Hydrogel spacer prospective multicenter randomized controlled pivotal trial: Dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):971-7.
* A Randomised Feasibility Study Evaluating Stereotactic Prostate RadioTherapy in High-Risk Localised Prostate Cancer With or Without Elective Nodal Irradiation SPORTS High-Risk Study. Sponsored by Boston Scientific.
** Dose-escalated prostate stereotactic radiotherapy: A feasibility study using rectal spacer and urethra sparing. Lewin Ron, Bar-Orian Idan, Honig Nir, Tsvang Lev, Ben-Ayun Maoz, Weiss Ilana, Simon Zvi
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labelingsupplied with each device. Information for use only in countries with applicable health authority registrations. This material not intended for use in France.
Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. Please check availability with your local sales representative or customer service.
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.